Sponsor hub

Johns Hopkins University clinical trial failures

Review 121 stopped clinical trials from Johns Hopkins University, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 5 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials121
Likely biological signals5
Shown below100

Dominant stop reasons

OPERATIONAL
67
OTHER/UNKNOWN
49
SAFETY
3
EFFICACY/FUTILITY
2

Notable sponsors

Johns Hopkins University
121

Related phases

Phase II
34
Phase I
30
Phase IV
27
Unknown
15
Early Phase I
10

Crawlable stopped-trial records

Open Explore

Showing up to 100 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT06810765: Trifecta Research Study

Phase II PTSD - Post Traumatic Stress Disorder trial by Johns Hopkins University. Stop reason: OTHER/UNKNOWN.

Study is being conducted externally.

NCT03081117: Intranasal Insulin for the Treatment of HAND

Phase I HIV Dementia trial by Johns Hopkins University. Stop reason: SAFETY.

On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment 10/16/2020 after interim data were reviewed by the DSMB and NIH.